Director/PDMR Shareholding
Notification of Transactions by Directors/Persons Discharging Managerial Responsibility
Dr. Martens plc (the "Company") announces that it has been notified of the following transactions in the Company's Ordinary shares undertaken on behalf of directors / persons discharging managerial responsibility ('PDMRs') under the Company's Global Bonus Scheme.
Under the terms of the Company's Remuneration Policy, one third of any annual bonus payable to the Executive Directors each year, net of tax and national insurance, will be used to purchase shares which the Executive Directors are required to hold for two years.
The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the Market Abuse Regulation.
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||
a) |
Name |
Kenny Wilson |
||||||
2 |
Reason for the notification |
|||||||
a) |
Position/status |
PDMR (Chief Executive Officer) |
||||||
b) |
Initial notification/Amendment |
Initial notification |
||||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
a) |
Name |
Dr. Martens plc |
||||||
b) |
LEI |
213800QPT8YM6NQZPH28 |
||||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of GBP 0.01
ISIN: GB00BL6NGV24 |
||||||
b) |
Nature of the transaction |
Purchase of Ordinary shares under the Global Bonus Scheme |
||||||
c) |
Price(s) and volume(s) |
|
||||||
d) |
Aggregated information
|
|
||||||
e) |
Date of the transaction |
2022-07-25 |
||||||
f) |
Place of the transaction |
London Stock Exchange (XLON) |
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||
a) |
Name |
Jon Mortimore |
||||||
2 |
Reason for the notification |
|||||||
a) |
Position/status |
PDMR (Chief Financial Officer) |
||||||
b) |
Initial notification/Amendment |
Initial notification |
||||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
a) |
Name |
Dr. Martens plc |
||||||
b) |
LEI |
213800QPT8YM6NQZPH28 |
||||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of GBP 0.01
ISIN: GB00BL6NGV24 |
||||||
b) |
Nature of the transaction |
Purchase of Ordinary shares under the Global Bonus Scheme |
||||||
c) |
Price(s) and volume(s) |
|
||||||
d) |
Aggregated information
|
|
||||||
e) |
Date of the transaction |
2022-07-25 |
||||||
f) |
Place of the transaction |
London Stock Exchange (XLON) |